45 minutes + live Q&A
The COVID-19 pandemic has taught us the value of early detection and mass testing initiatives to prevent viral spread. As we strive to get back to "normal", what does the 2021/22 Flu Season hold for us? Public Health Agencies are calling for better testing methods that can detect and differentiate COVID-19 and Influenza. Join the Team at Norgen Biotek Corp. for our first MasterClass on October 7th, 10am EDT, where we will compare Influenza and COVID-19 and how they differ, better understand the similarities between them and discuss new and emerging methods for multiplex detection of both viruses. We will also look at the progression of COVID-19 detection assays and how it relates to how we are handling the fourth wave.
With over 10 years of molecular and biotechnology experience, Jaclyn has developed a global skill set that allows her to handle our international business efforts and produce synergetic experiences for our customers and distributors. Jaclyn has had the opportunity to develop international business strategies that encompass educating the market of Norgen’s scientific capabilities. From contract manufacturing, to increasing our global reach through our extensive distribution network, her business and scientific expertise has perpetuated what it means to be a part of Norgen’s culture and team.